tiprankstipranks
CytoDyn engages Syneos Health as CRO for Phase II oncology trial
PremiumThe FlyCytoDyn engages Syneos Health as CRO for Phase II oncology trial
3M ago
CytoDyn announces preliminary findings in study with SMC Laboratories
Premium
The Fly
CytoDyn announces preliminary findings in study with SMC Laboratories
3M ago
CytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
Premium
The Fly
CytoDyn CEO says leronlimab has ‘potential to be life-changing therapeutic’
3M ago
CytoDyn announces start of preclinical MASH study
PremiumThe FlyCytoDyn announces start of preclinical MASH study
6M ago
CytoDyn issues letter to shareholders
Premium
The Fly
CytoDyn issues letter to shareholders
7M ago
CytoDyn to host business news update conference call
Premium
The Fly
CytoDyn to host business news update conference call
10M ago
CytoDyn Releases Regulatory FD Disclosure Information
PremiumCompany AnnouncementsCytoDyn Releases Regulatory FD Disclosure Information
11M ago
CytoDyn Announces Executive Leadership Changes and Appointments
Premium
Company Announcements
CytoDyn Announces Executive Leadership Changes and Appointments
11M ago
CytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
Premium
The Fly
CytoDyn appoints Jacob Lalezari as CEO, Michael Cohen as interim CFO
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100